Arch Biopartners Inc.
ARCH.V
TSX
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 26.12% | 61.73% | 9.24% | -38.40% | -80.81% |
| Total Depreciation and Amortization | -- | -- | -- | -- | -- |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 33.90% | -104.19% | 358.11% | -71.49% | 392.67% |
| Change in Net Operating Assets | -- | -- | -- | -- | -- |
| Cash from Operations | 44.26% | 34.52% | 36.21% | -102.94% | -51.81% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -82.04% | 43.10% | -70.29% | -44.77% | -70.19% |
| Total Debt Repaid | -128.62% | -2.94% | 77.58% | 81.02% | 80.32% |
| Issuance of Common Stock | 3.05% | -8.32% | 79.32% | 613.18% | 1,313.59% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -40.55% | 0.37% | 33.40% | 322.85% | 27.31% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 80.56% | 99.93% | 108.94% | 100.62% | -271.80% |